Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never use among 984 breast cancer patients

British Journal of Cancer

Volumn 80, Issue 9, 1999, Pages 1453-1458

  Jernstrom H ^a   Frenander, J ^a   Ferno M ^a   Olsson, H ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Breast cancer; HRT; Oestrogen receptor; Overall survival; Progesterone receptor

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; PROGESTERONE; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; ESTROGEN THERAPY; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MENOPAUSAL SYNDROME; PRIORITY JOURNAL; SWEDEN;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0032989896     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690543     Document Type: Article

References (28)

1. Bergkvist L, Adami H-O, Persson I, Bergström R and Krusemo CB (1989) Prognosis after breast cancer diagnosis exposed to estrogen and estrogen-progestogen replacement therapy. Am J Epidemiol 130: 221-228
2. Bonnier P, Romain S, Giacalone PL, Laffargue F, Martin PM and Piana L. (1995) Clinical and biologic prognostic factors in breast cancer diagnosed during postmenopausal hormone replacement therapy. Obstet Gynecol 85: 11-17
3. Brinton LA, Hoover R and Fraumeni JF Jr (1986) Menopausal oestrogens and breast cancer risk: an expanded case-control study. Br J Cancer 54: 825-832
4. Collaborative Group on Hormonal Factors in Breast Cancer (1997) Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer. Lancet 350: 1047-1059
5. Fernö M, Borg Å and Norgren A (1983) A comparison of two steroid receptor assays in breast cancer: dextran coated charcoal and isoelectric focusing. Anticancer Res 3: 243-246
6. Fernö M. Borg Å and Sellberg G (1986) Enzyme immuno assay of the estrogen receptor in breast cancer biopsy samples. A comparison with isoelectric focusing. Acta Radiol Oncol 25: 171-175
7. Fernö M, Borg Å and Johansson U (1989)) Enzyme immuno assay of progesterone receptor in breast cancer biopsy samples. A comparison with the dextran coated charcoal method. Acta Oncol 28: 19-22
8. Grodstein F, Stampfer MJ, Colditz GA, Willett WC, Manson JE, Joffe M, Rosner B, Fuchs C, Hankinson SE, Hunter DJ, Hennekens CH and Speizer FE (1997) Postmenopausal hormone therapy and mortality. N Engl J Med 336: 1769-1775
9. Harding C, Knox WF, Faragher EB, Baildam A and Bundred NJ (1996) Hormone replacement therapy and tumour grade in breast cancer: prospective study in screening unit. Br Med J 312: 1646-1647
10. Henderson BE, Paganini-Hill A and Ross RK (1991) Decreased mortality in users of estrogen replacement therapy. Arch Intern Med 151: 75-78
11. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B and Vittinghoff E (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280: 605-613
12. Hunt K, Vessey M and McPherson K (1990) Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis. Br J Obstet Gynecol 97: 1080-1086
13. Hunter D and Willet W (1993) Diet, body size, and breast cancer. Epidemiol Rev 15: 110-132
14. Jones C, Ingram D, Mattes E, and Hahnel R (1994) The effect of hormone replacement therapy on prognostic indices in women with breast cancer. Med J Aust 161: 106-110
15. Magnusson C, Holmberg L, Norden T, Lindgren A and Persson I (1996) Prognostic characteristic in breast cancers after hormone replacement therapy. Breast Cancer Res Treat 38: 325-334
16. Matthews KA, Kuller LH, Wing RR, Meilahn EN and Plantinga P (1996) Prior to use of estrogen replacement therapy, are users healthier than non-users? Am J Epidemiol 143: 971-978
17. Nischan P, Thomas DB and Ebeling K (1992) Accuracy of recall of use of an intrauterine device. Contraception 45: 363-368.
18. Nyström L, Rutqvist LE, Wall S, Lindgren A, Lindqvist M, Ryden S Andersson I, Bjurstam N, Fagerberg G, Frisell J, Tabor L and Larsson LG (1993) Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 341: 973-978
19. Olsson H and Hägglund G (1992) Reduced cancer morbidity and mortality in a prospective cohort of women with distal forearm fractures. Am J Epidemiol 136: 422-427
20. Persson I, Bergkvist L, Lindgren C and Yuen J (1997) Hormone replacement therapy and major risk factors for reproductive cancers, osteoporosis, and cardiovascular diseases: evidence of confounding by exposure characteristics. J Clin Epidemiol 50: 611-618
21. Salmon R, Remvikos Y, Ansquer Y and Asselain B (1995) HRT and breast cancer. Lancet 346: 1702-1703
22. Schairer C, Byrne C, Keyl PM, Brinton LA, Sturgeon SR and Hoover RN (1994) Menopausal estrogen and estrogen-progestin therapy and risk of breast cancer (United States). Cancer Causes Control 5: 491-500
23. Sigurdsson H, Baldetorp B, Borg A, Dahlberg M, Fernö M, Killander D and Olsson H (1990) Indicators of prognosis in node-negative breast cancer. N Engl J Med 322: 1045-1053
24. Squitieri R, Tartter PI, Ahmed S, Browser ST and Theise ND (1994) Carcinoma of the breast in postmenopausal hormone user and nonuser control groups. J Am Coll Surg 178: 167-170
25. Strickland DM, Gambrell RD Jr, Butzin CA and Strickland K (1992) The relationship between breast cancer survival and prior postmenopausal estrogen use. Obstet Gynaecol 80: 400-404
26. Sullivan JM, Vander Zwaag R, Hughes JP, Maddock V, Kroetz FW, Ramanathan KB and Mirvis DM (1990) Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women. Arch Intern Med 150: 2557-2562
27. Willis DB, Calle EE, Miracle-McMahill HL and Heath CW Jr (1996) Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States. Cancer Causes Control 7: 449-457
28. Yuen J, Persson J, Bergqvist L, Hoover R, Schairer C and Adami H-O (1993) Hormone replacement therapy and breast cancer mortality in Swedish women: results after adjustment for 'healthy drug-user' effect. Cancer Causes Control 4: 369-374